 Over the past 5-7 years, there has been a renewed research interest into the mechanism as well as the development of newer "emerging" treatment modalities for atrial fibrillation. One of these novel therapies is the implantable atrial defibrillator. In this article we will review the basic and clinical research which has been used in the development of electrode systems and shock waveforms utilized by commercially-available implantable atrial cardioversion devices.  
